Bergsmark C, Kristensen VA, Sjåmo MB, Høivik ML, Anisdahl K(2026) Therapeutic drug monitoring in inflammatory bowel disease patients switching from intravenous to subcutaneous infliximab: insights from a prospective real-world study Scand J Gastroenterol, 1-11(in press) DOI 10.1080/00365521.2026.2645083, PubMed 41902476
Hansen SH, Bhattacharjee N, Hu C, Maseng MG, Grannö O, Bang C, Olbjørn C, Perminow G, Valeur J, Bengtson MB, Frigstad SO, Andersen S, Aabrekk TB, Detlie TE, Franke A, Kristensen VA, Halfvarson J, Høivik ML, Iyer RK, Hov J(2026) Bacterial clusters are associated with the risk of severe disease progression in inflammatory bowel disease irrespective of conventional disease categories Microbiome Res Rep, 5(1), 4 DOI 10.20517/mrr.2025.96, PubMed 42016722
